Search Results

Filter
  • 1-10 of  37 results for ""Symptom Flare Up""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations.

  • Authors : Montemayor K; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States. Electronic address: .; Psoter KJ

Subjects: Symptom Flare Up*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Nov; Vol. 20 (6), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis.

Subjects: Symptom Flare Up*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Nov; Vol. 20 (6), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review.

  • Authors : McLeod C; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, 15 Hospital Ave, Nedlands WA 6009, Australia; Infectious Diseases Department, Perth Children's Hospital, 15 Hospital Ave, Nedlands 6009, Australia

Subjects: Symptom Flare Up*; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*physiopathology; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/mortality

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2020 Nov; Vol. 19 (6), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria.

  • Authors : Castner LM; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.; Zimbric M

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Bacteria, Anaerobic/Bacteria, Anaerobic/Bacteria, Anaerobic/*drug effects ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Nov; Vol. 20 (6), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF).

  • Authors : Frost F; Adult CF Centre, Liverpool Heart & Chest Hospital, UK; Institute of Infection & Global Health, University of Liverpool, UK. Electronic address: .

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Aztreonam/Aztreonam/Aztreonam/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Nov; Vol. 20 (6), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Continuous glucose monitoring indices predict poor FEV 1 recovery following cystic fibrosis pulmonary exacerbations.

  • Authors : Pallin M; Monash Lung and Sleep, Monash Medical Centre, 246 Clayton Road, Clayton VIC 3168, Victoria, Australia. Electronic address: .; Kumar S

Subjects: Blood Glucose Self-Monitoring* ; Forced Expiratory Volume*; Blood Glucose/Blood Glucose/Blood Glucose/*metabolism

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Sep; Vol. 20 (5), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of endoscopic sinus surgery on clinical outcomes in DeltaF508 cystic fibrosis patients.

  • Authors : Dadgostar A; St. Paul's Sinus Centre, Division of Otolaryngology, University of British Columbia, Vancouver, BC, Canada.; Nassiri S

Subjects: Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*complications ; Endoscopy/Endoscopy/Endoscopy/*methods ; Rhinitis/Rhinitis/Rhinitis/*surgery

  • Source: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2021 Sep; Vol. 46 (5),Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101247023 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis.

  • Authors : VanDevanter DR; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland OH, USA. Electronic address: .; Heltshe SL

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*complications ; Pseudomonas Infections/Pseudomonas Infections/Pseudomonas Infections/*drug therapy

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Mar; Vol. 20 (2), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.

  • Authors : Kaplan S; Teva Pharmaceutical Industries Ltd., Netanya, Israel. Electronic address: .; Lee A

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Colistin/Colistin/Colistin/*analogs & derivatives ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*complications

  • Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Mar; Vol. 20 (2), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends.

  • Authors : Gifford AH; Section of Pulmonary Medicine, 5C, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03756, USA. .; Polineni D

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy ; Iron/Iron/Iron/*blood

  • Source: Scientific reports [Sci Rep] 2021 Mar 01; Vol. 11 (1), pp. 4897. Date of Electronic Publication: 2021 Mar 01.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  37 results for ""Symptom Flare Up""